24 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
practices. These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements … in the preparation of our consolidated financial statements.
Revenue Recognition
We recognize revenue when our customer obtains control of promised goods
S-1/A
es2nfj 6g4h0t0t
13 Oct 22
IPO registration (amended)
10:51am
S-1
EX-10.22
wlo8vcu 6c0
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.14
e9itso
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.19
glot5tldgh qk2bhhm
23 Sep 22
IPO registration
4:12pm
S-1
osc023v
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.4
7wyc1
23 Sep 22
IPO registration
4:12pm
DRS/A
0bc1gpvh 5xhg3wtyo
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
yowwto0vyn3a38wk 3x
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
7tllc5g4mm hz
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
xc4v4qro 0dp03uv382
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.20
fj08 d5pyln0b
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
s7tt3stwvv
7 Mar 22
Draft registration statement (amended)
12:00am
DRSLTR
jl1sq8in52m4u5euct
7 Mar 22
Correspondence regarding draft registration statement
12:00am
DRS/A
4pquuqt3i0c4j51pe
7 Mar 22
Draft registration statement (amended)
12:00am
UPLOAD
oipvffunmf6bk2ij
17 Feb 22
Letter from SEC
12:00am